Education
About Us
Working with TipRanks
Follow Us
Indoco Remedies Limited (IN:INDOCO)
:INDOCO
INDOCO Stock Chart & Stats
Day’s Range― - ―
52-Week Range₹190.00 - ₹385.50
Previous CloseN/A
Volume47.33K
Average Volume (3M)4.75K
Market Cap
₹30.06B
Enterprise Value₹40.31B
Total Cash (Recent Filing)₹417.30M
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)96.2
Beta1.26
Next Earnings
Jul 24, 2025EPS EstimateN/A
Last Dividend Ex-Date
Sep 19, 2024Dividend Yield0.46%
Share Statistics
EPS (TTM)-4.40
Shares Outstanding92,247,900
10 Day Avg. Volume5,172
30 Day Avg. Volume4,753
Financial Highlights & Ratios
PEG Ratio0.09
Price to Book (P/B)2.92
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Indoco Remedies Limited News
PremiumCompany Announcements
Indoco Remedies to Host 10th Annual Analyst Conference
PremiumCompany Announcements
Indoco Remedies Cleared of GST Proceedings, No Financial ImpactINDOCO FAQ
What was Indoco Remedies Limited’s price range in the past 12 months?
Indoco Remedies Limited lowest stock price was ₹190.00 and its highest was ₹385.50 in the past 12 months.
What is Indoco Remedies Limited’s market cap?
Indoco Remedies Limited’s market cap is ₹30.06B.
When is Indoco Remedies Limited’s upcoming earnings report date?
Indoco Remedies Limited’s upcoming earnings report date is Jul 24, 2025 which is in 8 days.
How were Indoco Remedies Limited’s earnings last quarter?
Indoco Remedies Limited released its earnings results on May 22, 2025. The company reported -₹4.4 earnings per share for the quarter, missing the consensus estimate of ₹1.65 by -₹6.05.
Is Indoco Remedies Limited overvalued?
According to Wall Street analysts Indoco Remedies Limited’s price is currently Overvalued.
Does Indoco Remedies Limited pay dividends?
Indoco Remedies Limited pays a Annually dividend of ₹1.5 which represents an annual dividend yield of 0.46%. See more information on Indoco Remedies Limited dividends here
What is Indoco Remedies Limited’s EPS estimate?
Indoco Remedies Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Indoco Remedies Limited have?
Indoco Remedies Limited has 92,247,900 shares outstanding.
What happened to Indoco Remedies Limited’s price movement after its last earnings report?
Indoco Remedies Limited reported an EPS of -₹4.4 in its last earnings report, missing expectations of ₹1.65. Following the earnings report the stock price went down -6.887%.
Which hedge fund is a major shareholder of Indoco Remedies Limited?
Currently, no hedge funds are holding shares in IN:INDOCO
Company Description
Indoco Remedies Limited
Indoco Remedies Limited (INDOCO) is a pharmaceutical company based in India, engaged in the manufacturing and marketing of a wide range of pharmaceutical formulations. The company operates in various sectors, including prescription drugs, over-the-counter (OTC) products, and active pharmaceutical ingredients (APIs). Indoco's core products include generics, branded generics, and APIs, catering to various therapeutic segments such as anti-infectives, anti-diabetics, cardiovascular, anti-cancer, and respiratory medications.
Technical Analysis
Advanced Enzyme Technologies Ltd
―
Alembic Limited
―
Panacea Biotec Limited
―
SMS Pharmaceuticals Limited
―
Zota Health Care Ltd.
―